These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3534021)

  • 1. Clinical experience with topical tretinoin in the treatment of cervical dysplasia.
    Meyskens FL; Surwit ES
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):826-9. PubMed ID: 3534021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.
    Graham V; Surwit ES; Weiner S; Meyskens FL
    West J Med; 1986 Aug; 145(2):192-5. PubMed ID: 3765597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy.
    Weiner SA; Surwit EA; Graham VE; Meyskens FL
    Invest New Drugs; 1986; 4(3):241-4. PubMed ID: 3818228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of cancer of uterine cervix: a study on chemoprevention of retinamide II from cervical precancerous lesions.
    Ruidi C; Aihua D; Peiyu B; Zhongru G; Huazao L; Shifeng S; Rui H; Shiping X
    J Cell Biochem Suppl; 1997; 28-29():140-3. PubMed ID: 9589359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
    Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
    J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of topical tretinoin in melanoma and dysplastic nevi.
    Meyskens FL; Edwards L; Levine NS
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):822-5. PubMed ID: 3534020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions.
    Surwit EA; Graham V; Droegemueller W; Alberts D; Chvapil M; Dorr RT; Davis JR; Meyskens FL
    Am J Obstet Gynecol; 1982 Aug; 143(7):821-3. PubMed ID: 7048932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III.
    Ruffin MT; Bailey JM; Normolle DP; Michael CW; Bieniasz ME; Kmak DC; Unger ER; Brenner DE
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2148-52. PubMed ID: 15598773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial.
    Alvarez RD; Conner MG; Weiss H; Klug PM; Niwas S; Manne U; Bacus J; Kagan V; Sexton KC; Grubbs CJ; Eltoum IE; Grizzle WE
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):114-9. PubMed ID: 12582020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia.
    Peng YM; Alberts DS; Graham V; Surwit EA; Weiner S; Meyskens FL
    Invest New Drugs; 1986; 4(3):245-9. PubMed ID: 3818229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer.
    Abu J; Batuwangala M; Herbert K; Symonds P
    Lancet Oncol; 2005 Sep; 6(9):712-20. PubMed ID: 16129372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a contingency recruitment plan for a phase III chemoprevention trial of cervical dysplasia.
    Loescher LJ; Graham VE; Aickin M; Meyskens FL; Surwit EA
    Prog Clin Biol Res; 1990; 339():151-63. PubMed ID: 2202990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical dysplasia regression induced by all-trans-retinoic acid.
    Sporn MB; Roberts AB
    J Natl Cancer Inst; 1994 Apr; 86(7):476-7. PubMed ID: 8133526
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of retinoic acid on HPV titration and colposcopic changes in Korean patients with dysplasia of the uterine cervix.
    Ahn WS; Lee JM; Namkoong SE; Lee HY; Kim SJ
    J Cell Biochem Suppl; 1997; 28-29():133-9. PubMed ID: 9589358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of other topical retinoids.
    Strauss JS
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):905-6. PubMed ID: 2945845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on chemoprevention of retinamide II from cervical precancerous lesions].
    Chen RD; Ding AH; Han R
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Mar; 28(2):75-7. PubMed ID: 7924650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of topical tretinoin on dysplastic nevi. A preliminary trial.
    Edwards L; Jaffe P
    Arch Dermatol; 1990 Apr; 126(4):494-9. PubMed ID: 2321994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical use of vitamin A and E in gynecology].
    Pozzi V; Luciani S; Marino S; Nusiner MP
    Acta Vitaminol Enzymol; 1985; 7 Suppl():79-83. PubMed ID: 3916049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topical tretinoin on dysplastic nevi.
    Halpern AC; Schuchter LM; Elder DE; Guerry D; Elenitsas R; Trock B; Matozzo I
    J Clin Oncol; 1994 May; 12(5):1028-35. PubMed ID: 8164026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoprevention of cancer of the uterine cervix--preliminary study on the intervention of the cervical precancerous lesion by retinamide RII].
    Chen RD; Wang RZ; Luo HZ; Liu Y; Bao PY; Li XL; Li FR; Guo ZR; Han R; Li LM
    Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):348-50. PubMed ID: 3452524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.